185 related articles for article (PubMed ID: 35525337)
1. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
[TBL] [Abstract][Full Text] [Related]
2. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A
Radiology; 2020 Jan; 294(1):98-107. PubMed ID: 31743083
[TBL] [Abstract][Full Text] [Related]
3. Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
Lee HJ; Hong SB; Lee NK; Kim S; Seo HI; Kim DU; Han SY; Choo KS
Eur Radiol; 2021 Nov; 31(11):8606-8614. PubMed ID: 33881570
[TBL] [Abstract][Full Text] [Related]
4. Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.
Aslan S; Eryuruk U; Tasdemir MN; Cakir IM
Abdom Radiol (NY); 2022 Jul; 47(7):2325-2334. PubMed ID: 35672474
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI.
Heo S; Lee SS; Kim SY; Lim YS; Park HJ; Yoon JS; Suk HI; Sung YS; Park B; Lee JS
Korean J Radiol; 2022 Dec; 23(12):1269-1280. PubMed ID: 36447415
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of the gadoxetic acid MRI-derived relative enhancement index (REI) and functional liver imaging score (FLIS) in predicting liver function: validation with Albumin-Bilirubin (ALBI) grade.
Eryuruk U; Tasdemir MN; Karasu HI; Aslan S
Abdom Radiol (NY); 2024 May; 49(5):1456-1466. PubMed ID: 38653813
[TBL] [Abstract][Full Text] [Related]
7. The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
Cai S; Lin N; Yang Y; Ma W; Wang Y; Lin X; Wang X; Zhao X
Eur Radiol; 2023 May; 33(5):3425-3434. PubMed ID: 36897349
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters.
Bastati N; Wibmer A; Tamandl D; Einspieler H; Hodge JC; Poetter-Lang S; Rockenschaub S; Berlakovich GA; Trauner M; Herold C; Ba-Ssalamah A
Invest Radiol; 2016 Nov; 51(11):728-734. PubMed ID: 27175548
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
[TBL] [Abstract][Full Text] [Related]
10. Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.
Hwang JA; Min JH; Kim SH; Choi SY; Lee JE; Moon JY
Korean J Radiol; 2022 Apr; 23(4):389-401. PubMed ID: 35029076
[TBL] [Abstract][Full Text] [Related]
11. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM
Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301
[TBL] [Abstract][Full Text] [Related]
12. Inter-reader reliability of functional liver imaging score derived from gadoxetic acid-enhanced MRI: a meta-analysis.
Kim NH; Kang JH
Abdom Radiol (NY); 2023 Mar; 48(3):886-894. PubMed ID: 36576517
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of liver function in patients with liver cirrhosis and chronic liver disease using functional liver imaging scores at different acquisition time points.
Tang G; Liu J; Liu P; Huang F; Shao X; Chen Y; Xie A
Front Genet; 2022; 13():1071025. PubMed ID: 36561314
[No Abstract] [Full Text] [Related]
14. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease.
Beer L; Bastati N; Ba-Ssalamah A; Pötter-Lang S; Lampichler K; Bican Y; Lauber D; Hodge J; Binter T; Pomej K; Simbrunner B; Semmler G; Trauner M; Mandorfer M; Reiberger T
Liver Int; 2020 Nov; 40(11):2797-2807. PubMed ID: 32816394
[TBL] [Abstract][Full Text] [Related]
15. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase.
Zhang WY; Sun HY; Zhang WL; Feng R
Sci Rep; 2023 Jan; 13(1):543. PubMed ID: 36631556
[TBL] [Abstract][Full Text] [Related]
16. T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.
Yang W; Kim JE; Choi HC; Park MJ; Choi HY; Shin HS; Won JH; Han F; Nickel MD; Cho HC
Eur Radiol; 2021 Nov; 31(11):8376-8387. PubMed ID: 33782768
[TBL] [Abstract][Full Text] [Related]
17. Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic Implications.
Asenbaum U; Ba-Ssalamah A; Mandorfer M; Nolz R; Furtner J; Reiberger T; Ferlitsch A; Kaczirek K; Trauner M; Peck-Radosavljevic M; Wibmer AG
Invest Radiol; 2017 Aug; 52(8):462-469. PubMed ID: 28622247
[TBL] [Abstract][Full Text] [Related]
18. Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.
Liu C; Sun Y; Yang Y; Feng Y; Xie X; Qi L; Liu K; Wang X; Zhu Q; Zhao X
Eur Radiol; 2021 Aug; 31(8):5840-5850. PubMed ID: 33533990
[TBL] [Abstract][Full Text] [Related]
19. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M
Eur Radiol; 2023 Feb; 33(2):1422-1432. PubMed ID: 36166087
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis.
Simbrunner B; Hartl L; Jachs M; Bauer DJM; Scheiner B; Hofer BS; Stättermayer AF; Marculescu R; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2023 May; 5(5):100712. PubMed ID: 37035457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
